comprehensive -WSS

comprehensive

author：knowledge 2025-09-06 02:12:55 - browse：711

Balance innovation — Medicare laid out in the greatest detail yet how it will choose which drug prices it will negotiate in its brand-new program, and how it will figure out what the government’s opening offer will be. Adobe

WASHINGTON — Medicare laid out Wednesday in the greatest detail yet how it will choose which drug prices it will negotiate in its brand-new program, and how it will figure out what the government’s opening offer will be.

Democrats outlined some parts of the process in the Inflation Reduction Act that passed Congress last August, but the details of how drugs will be selected and what factors will be considered have been vague until now. Though the actual negotiated prices won’t take effect for years, Medicare officials must announce the first 10 drugs they’ll negotiate over by Sept. 1.

The guidance clarifies that the agency will choose the 50 pharmacy drugs that cost Medicare the most money, based on gross expenditures. If drugs have the same cost to the program, then the one that has been approved longer will be ranked higher.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： H5N1 bird flu virus started spreading in cows in Texas in December

entertainment

WSS

Cholera vaccine supply gets boost as demand surges globally

Medical bills so high, Medicare adding extra digits to claim forms

Anxious about a speech? A startup wants you to pop a minty cardiac drug

H5N1 bird flu found in pasteurized milk: what we know

Exact Sciences stock tumbles despite strong cancer detection sales

Readers respond to H5N1 and livestock movements, and more

focus

comprehensive

leisure time

Medicare details structure of new drug price negotiation program

Why rehabilitation engineers need to center patients in their research

State Dept. review finds Biden bears some blame for Afghanistan failures

HIV vaccine remains elusive. Immunologists keep trying new ideas

Medicare details structure of new drug price negotiation program

Dogs on Prozac: What pet anti

Medical leaders decry Supreme Court decision on affirmative action

Addiction experts warn against a second 'war on drugs'

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Big Tobacco's 'harm reduction': Is it for real, or a sham?

focus

Case highlights the risks of experimental stem cell therapy

Big Tobacco's 'harm reduction': Is it for real, or a sham?

MultiPlan and major insurers sued for alleged medical price

NVIDIA and Google execs on the future of AI and drug discovery

Arc Institute generative AI designs new CRISPR systems

Bird flu: Don't repeat Covid's 'health versus the economy' framing

entertainment

entertainment

focus

hotspot